Fergus Keane

Hematology Oncology

Memorial Sloan Kettering Cancer Center
300 E 66th St, New York,
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

National Trends in Early-Onset Colorectal Cancer: Incidence and Challenges in the Republic of Ireland.

National Trends in Early-Onset Colorectal Cancer: Incidence and Challenges in the Republic of Ireland.

Journal: JCO global oncology

Published: February 04, 2026

Dual pancreatic carcinomas: clonally related or independent primaries?

Dual pancreatic carcinomas: clonally related or independent primaries?

Journal: NPJ precision oncology

Published: January 13, 2026

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Journal: Research square

Published: September 15, 2025

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Journal: Nature medicine

Published: August 09, 2025

Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.

Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 18, 2025

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma.

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma.

Journal: Journal of the National Cancer Institute

Published: December 06, 2024

Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer.

Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer.

Journal: JAMA oncology

Published: September 05, 2024

Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort.

Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort.

Journal: Journal of the National Cancer Institute

Published: July 24, 2024

Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies.

Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies.

Journal: Clinical advances in hematology & oncology : H&O

Published: May 13, 2024

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy.

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy.

Journal: The oncologist

Published: March 08, 2024

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.

Journal: Journal of the National Cancer Institute

Published: January 10, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026